Você procurou por: fluconazolbehandling (Dinamarquês - Inglês)

plasmaeksponering (auc og cmax) for valdecoxib blev øget (henholdsvis 62% og 19%), når det blev administreret sammen med fluconazol (hovedsagelig en cyp2c9 hæmmer), hvilket viser, at dosis af parecoxibnatrium bør reduceres hos de patienter, der er i fluconazolbehandling.
plasma exposure (auc and cmax) to valdecoxib was increased (62% and 19%, respectively) when co- administered with fluconazole (predominantly a cyp2c9 inhibitor), indicating that the dose of parecoxib sodium should be reduced in those patients who are receiving fluconazole therapy.